ANI PHARMACEUTICALS INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Ani Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2013 to Q1 2024.
  • Ani Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$19.7M, a 334% decline year-over-year.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $67.4M.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$5.13M, a 103% decline from 2021.
  • Ani Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $195M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$19.7M -$15.2M -334% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 -$4.55M -$2.28M -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 -$2.27M +$455K +16.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 -$2.73M -$16.6M -120% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $13.9M +$12.7M +1052% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $1.21M +$1.04M +609% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $170K -$29.9M -99.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $30M +$32.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$2.36M -$2.37M -13183% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q1 2015 $18K -$47.7M -100% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-05
Q1 2014 $47.7M +$47.4M +12729% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q1 2013 $372K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.